Effect of mutations in Candida antarctica B lipase
Shamkant Patkar(Novo Nordisk (Denmark)), Ole Kirk(University of Copenhagen), Allan Svendsen(Novo Nordisk (Denmark)), Morten Würtz Christensen(Novozymes (Denmark)), Ebbe Kelstrup(Technical University of Denmark), Jesper Vind(Novozymes (Denmark)), Kristian Borch(Linköping University Hospital)
Cited by 58
Related Papers
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
One Biocatalyst–Many Applications: The Use of Candida Antarctica B-Lipase in Organic Synthesis
|Biocatalysis and Biotransformation|1998|682